Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cell and Tissue Banking|July 12, 2008
Banking human tissue for research: vision to realityChris Womack, Neil M GrayJournal of Experimental & Clinical Cancer Research : CR|June 3, 2014
AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer modelsZhaomei Mu, Teresa Klinowska, Xiaoshen Dong, et al.Biopharmaceutics & Drug Disposition|March 19, 2011
Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissueIain S Haslam, Derek A O'Reilly, David J Sherlock, et al.Methods (San Diego, Calif.)|February 15, 2014
Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchersWilliam J Howat, Arthur Lewis, Phillipa Jones, et al.Cancer Biomarkers : Section a of Disease Markers|November 19, 2015
Expression of potential biomarkers associated with homologous recombination repair in patients with ovarian or triple-negative breast cancerHiroyuki Nomura, Fumio Kataoka, Daisuke Aoki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapyNeil R Smith, Dawn Baker, Matthew Farren, et al.Anticancer Research|March 10, 2015
Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trialMegan J McGregor, Wakkas Fadhil, Rose Wharton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancersNeil R Smith, Dawn Baker, Neil H James, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancerN V Rajeshkumar, Aik Choon Tan, Elizabeth De Oliveira, et al.Histopathology|June 25, 2010
Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomasMichael G A Norwood, Neil Bailey, Manoj Nanji, et al.Pageof 2